Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
McKesson
AstraZeneca
Merck
Medtronic

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205692

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 205692 describes BASAGLAR, which is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. Additional details are available on the BASAGLAR profile page.

The generic ingredient in BASAGLAR is insulin glargine. There are forty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the insulin glargine profile page.
Summary for 205692
Tradename:BASAGLAR
Applicant:Eli Lilly And Co
Ingredient:insulin glargine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 205692
Ingredient-typeInsulin
Medical Subject Heading (MeSH) Categories for 205692
Suppliers and Packaging for NDA: 205692
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BASAGLAR insulin glargine SOLUTION;SUBCUTANEOUS 205692 NDA Eli Lilly and Company 0002-7715 0002-7715-59 5 SYRINGE in 1 CARTON (0002-7715-59) > 3 mL in 1 SYRINGE (0002-7715-01)
BASAGLAR insulin glargine SOLUTION;SUBCUTANEOUS 205692 NDA Eli Lilly and Company 0002-7715 0002-7715-63 1 SYRINGE in 1 CARTON (0002-7715-63) > 3 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;SUBCUTANEOUSStrength300 UNITS/3ML (100 UNITS/ML)
Approval Date:Dec 16, 2015TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Baxter
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.